These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7068940)

  • 1. Imipramine disposition in alcoholics.
    Ciraulo DA; Alderson LM; Chapron DJ; Jaffe JH; Subbarao B; Kramer PA
    J Clin Psychopharmacol; 1982 Feb; 2(1):2-7. PubMed ID: 7068940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers.
    Ciraulo DA; Barnhill JG; Jaffe JH
    Clin Pharmacol Ther; 1988 May; 43(5):509-18. PubMed ID: 3365915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis and disposition of imipramine and its active metabolites in man.
    Sutfin TA; DeVane CL; Jusko WJ
    Psychopharmacology (Berl); 1984; 82(4):310-7. PubMed ID: 6427820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous pharmacokinetics of 2-hydroxyimipramine in alcoholics and normal controls.
    Ciraulo DA; Barnhill JG; Jaffe JH; Ciraulo AM; Tarmey MF
    J Stud Alcohol; 1990 Jul; 51(4):366-72. PubMed ID: 2359311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting imipramine dose in children with depression.
    Sallee F; Stiller R; Perel J; Rancurello M
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose.
    DeVane CL; Simpkins JW
    Drug Metab Dispos; 1985; 13(4):438-42. PubMed ID: 2863107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine.
    DeVane CL; Jusko WJ
    Drug Intell Clin Pharm; 1981 Apr; 15(4):263-6. PubMed ID: 7274042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
    Sutfin TA; Perini GI; Molnar G; Jusko WJ
    J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of verapamil, diltiazem, and labetalol on the bioavailability and metabolism of imipramine.
    Hermann DJ; Krol TF; Dukes GE; Hussey EK; Danis M; Han YH; Powell JR; Hak LJ
    J Clin Pharmacol; 1992 Feb; 32(2):176-83. PubMed ID: 1613128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute bioavailability of imipramine: influence of food.
    Abernethyl DR; Divoll M; Greenblatt DJ; Harmatz JS; Shader RI
    Psychopharmacology (Berl); 1984; 83(1):104-6. PubMed ID: 6429693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipramine and desipramine disposition in the elderly.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1985 Jan; 232(1):183-8. PubMed ID: 3965690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronopharmacokinetics of imipramine and desipramine in rat forebrain and plasma after single and chronic treatment with imipramine.
    Lemmer B; Holle L
    Chronobiol Int; 1991; 8(3):176-85. PubMed ID: 1794155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic interaction between imipramine and carbamazepine in patients with major depression.
    Szymura-Oleksiak J; Wyska E; Wasieczko A
    Psychopharmacology (Berl); 2001 Feb; 154(1):38-42. PubMed ID: 11292004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine and its metabolites: relationship to cerebral catecholamines in rats in vivo.
    Barkai AI; Suckow RF; Cooper TB
    J Pharmacol Exp Ther; 1984 Aug; 230(2):330-5. PubMed ID: 6747838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction of disulfiram and antidepressants.
    Ciraulo DA; Barnhill J; Boxenbaum H
    Am J Psychiatry; 1985 Nov; 142(11):1373-4. PubMed ID: 4061700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
    Rogóz Z; Dziedzicka-Wasylewska M; Daniel WA; Wójcikowski J; Dudek D; Wróbel A; Zieba A
    Pol J Pharmacol; 2004; 56(6):735-42. PubMed ID: 15662086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of imipramine after single and multiple intravenous administration in rats.
    Szymura-Oleksiak J; Panas M; Chruściel W
    Pol J Pharmacol Pharm; 1983; 35(2):151-7. PubMed ID: 6622297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral and blood pharmacokinetics of imipramine and its active metabolites in the pregnant rat.
    DeVane CL; Simpkins JW; Stout SA
    Psychopharmacology (Berl); 1984; 84(2):225-30. PubMed ID: 6438681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of imipramine to platelet membranes is lower in alcoholics than in controls.
    Javors M; Blaisdell G; Lee J; Bowden C
    Alcohol Drug Res; 1987; 7(5-6):453-9. PubMed ID: 3620011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.